CRISPR Will Allow the Growth of Each Cancer Cell to Be Tracked

Cancer results from mutations in numerous tumor suppressor genes(such as p53). A central question in cancer genetics is how genes that have undergone mutations interact with one another and contribute to cancer development. According to research published in April 2018 in Nature Genetics, a method developed using CRISPR can track cancer-related mutations to examine how a single cell becomes a cancer cell . This method could greatly accelerate cancer research and drug development.
The fundamental cause of cancer is damage to genes. Mapping the genes involved in cancer and their interactions is highly challenging. Mutations have to be generated by manipulating genes in each mouse model, requiring thousands of mice. However, using this newly developed method and only 36 mice, researchers analyzed more lung cancer genotypes than had been analyzed in 15 years.
In this method, crispr was used to add short nucleotide sequences to the DNAof each cancer cell. Each of these sequences can be thought of as a genetic barcode that can be passed to offspring. Each time a cell divides, it passes this unique genetic barcode to its daughter cells. Thus, when tumor tissue is collected, DNA sequencing can be used to examine the changes in each cell.
What Does This Study Mean for Us?
- Tumors have a highly complex genetic structure that varies from patient to patient. With this newly developed technique, 30 different genetic variations can be modeled simultaneously. This will facilitate understanding of cancer's genetic structure.
- By examining thousands of genetic mutations, this newly developed method could enable rapid progress in drug discovery.
- The driver mutations that are the actual cause of cancer development can thereby be identified, revealing which mutations are important to cancer cells. An effective treatment can then be planned.
- An interesting finding from the research is that many tumor suppressor genes depend on one another. This may allow drugs to be designed for a treatment strategy called synthetic lethality .
- The 10 hallmarks of cancer
Sources
Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice.
Nature Genetics, 2018.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.